Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan's Kyoto U. iPS Researchers Report New Technique For Stem Cells

This article was originally published in PharmAsia News

Executive Summary

Researchers from Japan's Kyoto University report a new way of creating induced pluripotent stem cells, an advancement of their groundbreaking creation of cells from a mouse three years ago. The research team's new technique relies on the p53 gene known to prevent cancer in cells. Those cells are injected into mouse skin cells to create iPS cells with a 20 percent success rate, 10 times better than usual with such cells. Tests on human iPS cells also had an improved success rate, the researchers said. (Click here for more - a subscription may be required

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072434

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel